A Slc5a6-deficient mouse model reveals metabolically driven cardiomyopathy with therapeutic potential for vitamin-based intervention. - Fullerton MO; Phillips LC; Redgrave RE; Spray L; Haufroid V; Merces G; Kerridge ST; Richardson GD; Mercier N; Roland D; Crossley R; Morgan AD; et al. (JCI insight, 2026)